ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Biocon Biopharmaceuticals Private Limited
News »
latest
by relevance
Biocon Biopharmaceuticals becomes wholly owned subsidiary
Apr 06, 2010 at 18:49 | Source:
Moneycontrol.com
Biocon announced that its subsidiary company Biocon SA., has entered into a definitive agreement to acquire the 49% equity stake held by CIMAB SA in Biocon Biopharmaceuticals Private Limited (BBPL).
Biocon's revenues Rs 1090cr, EBITDA Rs 335cr, PAT Rs 225cr
Apr 23, 2008 at 19:02
Biocon Group Revenues Rs 1,090cr, EBITDA Rs 335cr, PAT Rs 225cr. Earnings per share at Rs 22.5 for the year.
Biocon's FY 2006-07 performance shows healthy growth
Apr 19, 2007 at 10:40
Biocon's FY 2006-07 performance shows healthy growth. Revenues Rs 990 cr, EBITDA Rs 287cr, PAT Rs 200cr
Biocons 9MFY07 delivers robust profits: Revenues Rs 710cr
Jan 18, 2007 at 10:41
Biocons 9 months FY 07 delivers robust profits: Revenues Rs. 710 crs
Clinigene Pride Study reaffirms INSUGEN Safety & Efficacy
Dec 27, 2006 at 11:55
Clinigene Pride Study reaffirms INSUGEN Safety & Efficacy
Biocon Biopharmaceuticals becomes wholly owned subsidiary
Apr 06, 2010 at 18:49 | Source:
Moneycontrol.com
Biocon announced that its subsidiary company Biocon SA., has entered into a definitive agreement to acquire the 49% equity stake held by CIMAB SA in Biocon Biopharmaceuticals Private Limited (BBPL).
Biocon's revenues Rs 1090cr, EBITDA Rs 335cr, PAT Rs 225cr
Apr 23, 2008 at 19:02
Biocon Group Revenues Rs 1,090cr, EBITDA Rs 335cr, PAT Rs 225cr. Earnings per share at Rs 22.5 for the year.
Biocon's FY 2006-07 performance shows healthy growth
Apr 19, 2007 at 10:40
Biocon's FY 2006-07 performance shows healthy growth. Revenues Rs 990 cr, EBITDA Rs 287cr, PAT Rs 200cr
Biocons 9MFY07 delivers robust profits: Revenues Rs 710cr
Jan 18, 2007 at 10:41
Biocons 9 months FY 07 delivers robust profits: Revenues Rs. 710 crs
Clinigene Pride Study reaffirms INSUGEN Safety & Efficacy
Dec 27, 2006 at 11:55
Clinigene Pride Study reaffirms INSUGEN Safety & Efficacy
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window